The Discounted Cash Flow (DCF) valuation of Collplant Biotechnologies Ltd (CLGN) is (4,598.55) USD. With the latest stock price at 1.93 USD, the upside of Collplant Biotechnologies Ltd based on DCF is -238366.9%.
Based on the latest price of 1.93 USD and our DCF valuation, Collplant Biotechnologies Ltd (CLGN) is a sell. selling CLGN stocks now will result in a potential gain of 238366.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.2% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (11,869.09) - (2,871.34) | (4,598.55) |
| Upside | -615078.6% - -148874.3% | -238366.9% |